Literature DB >> 2779243

Risk factors for neuropsychological impairment in alcoholics: antisocial personality, age, years of drinking and gender.

P Malloy1, N Noel, S Rogers, R Longabaugh, M Beattie.   

Abstract

One hundred eighty-two alcoholics were studied using subtests from the Halstead-Reitan Neuropsychological Battery, Wechsler Adult Intelligence Scale and the Wechsler Memory Scale. Alcoholics who displayed antisocial personality disorder (ASPD) were more impaired on the Brain Age Quotient, a summary measure of neuropsychological impairment. Multivariate analyses indicated that presence of ASPD contributed significantly to this impairment, independent of age, length of drinking history or gender. Discriminant analysis using these variables as predictors allowed for clinically useful levels of prediction of neuropsychological impairment in individual subjects.

Entities:  

Mesh:

Year:  1989        PMID: 2779243     DOI: 10.15288/jsa.1989.50.422

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  4 in total

1.  Risk factors and neuropsychological recovery in clients with alcohol use disorders who were exposed to different treatments.

Authors:  Marsha E Bates; Danielle Barry; Erich W Labouvie; William Fals-Stewart; Gerald Voelbel; Jennifer F Buckman
Journal:  J Consult Clin Psychol       Date:  2004-12

2.  Specificity of executive functioning and processing speed problems in common psychopathology.

Authors:  Joel T Nigg; Jennifer M Jester; Gillian M Stavro; Ka I Ip; Leon I Puttler; Robert A Zucker
Journal:  Neuropsychology       Date:  2017-01-16       Impact factor: 3.295

Review 3.  Alcohol, head injury, and neuropsychological function.

Authors:  D A Solomon; P F Malloy
Journal:  Neuropsychol Rev       Date:  1992-09       Impact factor: 7.444

4.  Frontal brain dysfunction in alcoholism with and without antisocial personality disorder.

Authors:  Marlene Oscar-Berman; Mary M Valmas; Kayle S Sawyer; Shalene M Kirkley; David A Gansler; Diane Merritt; Ashley Couture
Journal:  Neuropsychiatr Dis Treat       Date:  2009-06-10       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.